市場調查報告書
商品編碼
1466235
人工呼吸器市場:按移動性、模式、類型、介面和最終用戶分類 - 2024-2030 年全球預測Ventilators Market by Mobility (Intensive Care Ventilator, Portable Ventilator), Mode (Dual or Combined Mode Ventilation, Pressure Mode Ventilation, Volume Mode Ventilation), Type, Interface, End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年人工呼吸器市場規模為36.3億美元,2024年達38.5億美元,預計2030年將達55.4億美元,複合年成長率為6.22%。
人工呼吸器是醫療設備。它在重症患者,包括患有嚴重肺部疾病、神經系統疾病和創傷相關損傷的患者。新型冠狀病毒主要針對呼吸系統,引起類似肺炎的症狀,並可能進展為需要機械通氣才能生存的急性呼吸衰竭。呼吸系統疾病和術後護理的增加增加了對人工呼吸器,特別是在居家照護環境中。我們也努力向醫院和防區部署人工呼吸器,以支援充分的醫療保健。然而,人工呼吸器的技術限制阻礙了它們對特定疾病狀態的適用性。業界也發生了產品召回事件,凸顯了嚴格品管措施的必要性。具有先進功能的人工呼吸器的引入有望改善患者的治療效果並提高效率。政府對醫用人工呼吸器的核准為行業創新和成長創造了有利的環境。
主要市場統計 | |
---|---|
基準年[2023] | 36.3億美元 |
預測年份 [2024] | 38.5億美元 |
預測年份 [2030] | 55.4億美元 |
複合年成長率(%) | 6.22% |
流動性高階加護治療在重症加護環境中需要人工呼吸器
加護治療人工呼吸器是高性能重症患者監護設備,旨在為患有呼吸衰竭或其他需要機械通氣的嚴重醫療狀況的患者提供支援。該設備主要用於醫院和醫療機構的加護病房(ICU)、急診室以及手術室。可攜式人工呼吸器是一種緊湊、輕巧的設備,旨在為傳統醫院環境以外的地方的患者提供呼吸輔助,例如家庭護理、救護車、長期護理設施和設施間運輸。可攜式人工呼吸器的通用功能包括電池操作選項、安全警報、即時監控和方便用戶使用的介面。
模式:雙模式或組合模式通氣偏好,以提供最佳的呼吸支持
雙模式通氣或組合模式通氣是基於壓力和容量的策略的結合,可為患者提供最佳的呼吸支持。它旨在確保足夠的肺復張並防止過度充氣,同時允許臨床醫生同時控制潮氣量和吸氣壓。這種模式最大限度地提高了患者的舒適度以及與人工呼吸器的可調性,減少了人工呼吸器引起的肺損傷 (VILI) 等併發症的可能性。壓力模式通氣是急性呼吸窘迫症候群(ARDS) 和其他需要氣道壓力控制的疾病患者的合適選擇。在此方法中,人工呼吸器以指定壓力水平輸送呼吸,同時監測患者的吸氣強度。壓力模式通氣的主要優點是它緊密模仿自然呼吸模式,改善患者和人工呼吸器的同步性。對於機械通氣期間需要恆定潮氣量的患者來說,容量模式通氣仍然是首選。在該技術中,無論氣道壓力或肺順應性如何變化,人工呼吸器都會保持預設的潮氣量。它對於患有限制性肺病的患者特別有用,可以防止通氣不足並確保足夠的氣體交換。
新生兒人工呼吸器操作的改進可提供溫和的支持,防止因肺部發育不成熟和氣道脆弱而引起的併發症。
成人和兒童用人工呼吸器旨在為呼吸衰竭或功能不全的患者(通常為 1 歲以上)提供機械通氣。這些設備專為滿足該年齡層的獨特生理需求而量身定做,確保提供足夠的通氣支持,同時最大限度地降低擠壓傷等併發症的風險。新生兒或新生兒人工呼吸器可滿足新生兒(4 週以下)和嬰兒(1 歲以下)獨特的呼吸支援需求。早產兒常呼吸系統發育不全,導致早產兒呼吸暫停症候群、呼吸窘迫症候群、支氣管肺發育不良等病理狀況。新生兒人工呼吸器旨在提供溫和的通氣,同時最大限度地減少由於這些患者體質嬌弱而導致的氧中毒併發症。
由於界面併發症和低風險而採用非侵入性通氣
侵入性通氣涉及將氣管插管插入病人氣管,直接向肺部提供機械通氣。當患者嚴重或非侵入性呼吸支持方法不足或不足時,可使用此方法。非侵入性通氣 (NIV) 無需使用氣管插管即可提供呼吸支持。當患者病情嚴重且有創通氣併發症的併發症超過潛在益處時,可使用 NIV。這種方法通常用於慢性阻塞性肺病(COPD)惡化、急性呼吸衰竭以及某些睡眠障礙(例如阻塞型睡眠呼吸中止症)的情況。
最終用戶:醫院對具有許多先進功能的多功能人工呼吸器的需求
門診手術中心 (ASC) 是一家進行不需要住院的門診手術的醫療機構。 ASC 中對人工呼吸器的需求對於在各種外科手術期間提供呼吸支持至關重要。在居家醫療中,它主要用於在醫院外需要長期或慢性通氣支持的患者。在家庭護理環境中,需要具有更高可用性、低噪音水平、緊湊性和遠端監控功能的人工呼吸器,以最大限度地減少看護者的負擔,同時確保患者的安全和舒適。在醫院,重症監護病房 (ICU)、新生兒加護病房(NICU)、急診室 (ED) 以及心胸外科等專業外科手術的需求量很大,這些是呼吸器的主要使用案例。在這些環境中,人工呼吸器必須可靠、多功能,並提供廣泛的高級功能,例如保護性通氣策略、疏散通訊協定和自動決策支援。
區域洞察
在美洲,尤其是北美,人工呼吸器市場在疫情高峰期出現成長,並且由於術後護理的增加,需求持續增加。區域企業擴大了產能,並引進了先進的人工呼吸器,以滿足不斷成長的設備需求。在亞洲,人工呼吸器的需求在 2020 年初激增,催生了新的進入者。該地區擁有多元化的醫療基礎設施,創造了多元化的市場。中國和日本等國家是成熟的醫療設備製造商,而其他國家則發展迅速。亞洲企業抓住了這一機遇,擴大製造能力以滿足國內需求並向世界各地出口。在歐洲,義大利、西班牙和英國正致力於改善醫療基礎設施,頻繁升級包括人工呼吸器在內的醫療設備。該地區的醫療保健市場成熟,有關人工呼吸器品質的法規也很嚴格。該地區的市場開拓公司正在政府資助下致力於開發先進的人工呼吸器技術。
FPNV定位矩陣
FPNV定位矩陣對於評估人工呼吸器市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對人工呼吸器市場供應商的現狀進行富有洞察力和深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.人工呼吸器市場的市場規模和預測是多少?
2.人工呼吸器市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些?
3.人工呼吸器市場的技術趨勢和法規結構是什麼?
4.人工呼吸器市場主要廠商的市場佔有率是多少?
5.進入人工呼吸器市場合適的型態和策略手段是什麼?
[196 Pages Report] The Ventilators Market size was estimated at USD 3.63 billion in 2023 and expected to reach USD 3.85 billion in 2024, at a CAGR 6.22% to reach USD 5.54 billion by 2030.
A ventilator is a medical device that provides artificial respiration or assisted breathing to patients experiencing respiratory failure. It plays an essential role in managing severely ill patients, including those suffering from severe lung diseases, neurological conditions, and trauma-related injuries. The novel coronavirus primarily targets the respiratory system, leading to pneumonia-like symptoms that can progress into acute respiratory failure requiring mechanical ventilation for survival. The increasing incidence of respiratory diseases and post-surgical care has led to a rise in the requirement for ventilators, particularly in home care settings. There are initiatives to deploy ventilators in hospitals and defense areas to ensure adequate healthcare support. However, technical limitations of ventilators have hindered their compatibility with certain disease states. The industry has witnessed some product recalls, which focus on the need for strict quality control measures. The introduction of intelligent ventilators with advanced features is expected to improve patient outcomes and increase efficiency. Favorable government approvals for medical ventilators provide an encouraging environment for innovation and growth in the industry.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 3.63 billion |
Estimated Year [2024] | USD 3.85 billion |
Forecast Year [2030] | USD 5.54 billion |
CAGR (%) | 6.22% |
Mobility: Need for advanced intensive care ventilators for critical care settings
An intensive care ventilator is a high-performance, critical care device designed to support patients with respiratory failure or other severe medical conditions requiring mechanical ventilation. These devices are primarily used in intensive care units (ICUs), emergency departments, and operating rooms in hospitals and healthcare facilities. Portable ventilators are compact and lightweight devices designed for providing respiratory support to patients outside traditional hospital settings such as homecare settings, ambulances, long-term care facilities, or during interfacility transport. Some common features in portable ventilators include battery operation options, alarms for safety purposes, real-time monitoring, and user-friendly interfaces.
Mode: Preference for dual or combined mode ventilation to provide optimal respiratory support
Dual or combined mode ventilation is a fusion of pressure and volume-based strategies to provide optimal respiratory support to patients. It is designed to ensure adequate lung recruitment and prevent over-distension while allowing clinicians to control tidal volume and inspiratory pressure simultaneously. This mode maximizes patient comfort and synchrony with the ventilator, leading to reduced chances of complications such as ventilator-induced lung injury (VILI). Pressure mode ventilation is a suitable choice for patients with acute respiratory distress syndrome (ARDS) and other conditions requiring controlled airway pressures. In this method, the ventilator delivers breaths at a predetermined pressure level while monitoring the patient's inspiratory effort. The primary advantage of pressure mode ventilation is that it closely mimics natural breathing patterns, providing better patient-ventilator synchrony. Volume mode ventilation remains a preferred option for patients who require consistent tidal volumes during mechanical ventilation. Under this technique, the ventilator maintains a pre-set tidal volume regardless of changes in airway pressure or lung compliance. It is particularly useful in preventing hypoventilation and ensuring adequate gas exchange in patients with restrictive lung diseases.
Type: Improvements in operations of neonatal ventilators to enable gentle support that safeguards against complications from immature lungs and fragile airways
Adult and pediatric ventilators are designed to provide mechanical ventilation for patients with respiratory failure or insufficiency, typically aged one year and above. These devices are tailored to meet the unique physiological needs of this age group, ensuring adequate ventilation support while minimizing the risk of complications such as barotrauma. Infant or neonatal ventilators cater to the specific respiratory support needs of newborns (up to four weeks old) and infants (up to one-year-old). Premature babies often have underdeveloped respiratory systems, resulting in conditions such as apnea of prematurity, respiratory distress syndrome, and bronchopulmonary dysplasia. Neonatal ventilators are designed to provide gentle ventilation while minimizing complications of oxygen toxicity due to the delicate nature of these patients.
Interface: Adoption of non-invasive ventilation owing to their low complication and risks
Invasive ventilation involves placing an endotracheal (ET) tube into the trachea of the patient to deliver mechanical ventilation directly to the lungs. This method is preferred when a patient's condition is critical or when non-invasive methods are insufficient or unsuitable for adequate respiratory support. Non-invasive ventilation (NIV) delivers respiratory support without an endotracheal tube. NIV is used when the patient's condition is less severe and the risk of complications from invasive ventilation is greater than the potential benefits. This method is often employed in cases such as chronic obstructive pulmonary disease (COPD) exacerbations, acute respiratory failure, and certain sleep disorders such as obstructive sleep apnea.
End User: Requirement for highly versatile ventilators with numerous advanced features in hospitals
Ambulatory surgical centers (ASCs) are healthcare facilities that perform outpatient surgeries that do not require hospitalization. The need for ventilators in ASCs is essential, as these devices provide respiratory support during various surgical procedures. The home care setting primarily serves patients requiring long-term or chronic ventilation support outside the hospital environment. Users prefer ventilators with improved user-friendliness, low noise levels, compactness, and remote monitoring features to ensure patient safety and comfort while minimizing caregiver burden in homecare settings. Hospitals represent a major use case for ventilators due to the high need for critical care units (ICUs), neonatal intensive care units (NICUs), emergency departments (EDs), and more specialized surgical applications such as cardiothoracic surgery. In this setting, ventilators must be reliable and versatile and offer a wide range of advanced features such as lung-protective ventilation strategies, weaning protocols, and automated decision support.
Regional Insights
In the Americas, specifically in North America, the market for ventilators grew during the pandemic's peak and has continued to observe requirements owing to the rising cases of post-surgery care. Regional players expanded their production capacities and introduced advanced intelligent ventilators to meet the rising equipment requirements. Asia witnessed an abrupt increase in the need for ventilators during early 2020, which encouraged new regional companies to enter the market. The region portrays a diverse market with variations in healthcare infrastructure. Countries such as China and Japan have well-established medical equipment manufacturing companies, while others are developing rapidly. Asian firms seized this opportunity by expanding their manufacturing capabilities to cater to domestic needs and to export ventilators worldwide. In Europe, Italy, Spain, and the United Kingdom, with an emphasis on advancing healthcare infrastructure with frequent medical equipment upgrades, including ventilators. The region has a mature healthcare market with strong regulations on ventilator quality. Market players in the region are working on developing advanced ventilator technologies supported by government funding.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Ventilators Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Ventilators Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Ventilators Market, highlighting leading vendors and their innovative profiles. These include Abhay Raj International, Acoma Medical Industry Co Ltd., AgVa Healthcare, Air Liquide S.A., ARI Medical Technology Co., Ltd., Avante Health Solutions, aXcent medical GmbH, Baxter International Inc., Beijing Aeonmed Co., Ltd., Bio-Med Devices, Inc., Biosys Biyomedikal Muhendislik A.S., Bunnell Incorporated, CorVent Medical Inc., Dima Italia, Dragerwerk AG & Co. KGaA, eVent Medical, Fisher & Paykel Healthcare Limited, Flexicare Medical Limited, Flight-Medical Innovations Ltd., GE HealthCare Technologies, Inc., Getinge AB, Hamilton Medical AG, Hayek Medical by United Hayek Company, Healicom Medical Equipment Co., Ltd., Koninklijke Philips N.V., Leistung Brasil, Lowenstein Medical Innovation GmbH & Co. KG, Medtronic PLC, Nanjing Superstar Medical Equipment Co.,Ltd., Narang Medical Limited, Nihon Kohden Corporation, O-Two Medical Technologies Inc., Resmed, Inc., Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Siemens AG, Smith Group PLC, SMTC Corporation, Sysadvance-Sistemas de Engenharia, SA, Ventec Life Systems, Inc., Vexos Corporation, Vyaire Medical, Inc., WEINMANN Emergency Medical Technology GmbH + Co. KG, and Zoll Medical Corporation.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Ventilators Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Ventilators Market?
3. What are the technology trends and regulatory frameworks in the Ventilators Market?
4. What is the market share of the leading vendors in the Ventilators Market?
5. Which modes and strategic moves are suitable for entering the Ventilators Market?